Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Plos One|May 5, 2012
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer riskStian Knappskog, Liv B Gansmo, Pål Romundstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinomaElisabeth Wik, Maria B Ræder, Camilla Krakstad, et al.
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
The Lancet. Oncology|February 7, 2018
Chromatin organisation and cancer prognosis: a pan-cancer studyAndreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, et al.
Plos One|November 2, 2018
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancerKanthida Kusonmano, Mari K Halle, Elisabeth Wik, et al.
BMJ Open|January 16, 2021
A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarumCaitlin R Dean, Hyke Bierma, Ria Clarke, et al.
Oncotarget|August 27, 2015
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinomaCamilla Krakstad, Ingvild L Tangen, Erling A Hoivik, et al.
Oncotarget|January 1, 2017
Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survivalKaren Klepsland Mauland, Elisabeth Wik, Erling A Hoivik, et al.
Oncotarget|September 17, 2016
Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancerAnna Berg, Kristine E Fasmer, Karen K Mauland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2013
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibitionElisabeth Wik, Even Birkeland, Jone Trovik, et al.
Pageof 14